BioCardia: Nasdaq notice for equity $837K vs $2.5M minimum; plan due May 16

BioCardia, Inc.

Stockholders' equity of $837K as of Dec 31, 2024 is below Nasdaq's $2.5M minimum for continued listing.
Company must submit a compliance plan by May 16, 2025; Nasdaq may grant up to 180-day extension.
No immediate effect on trading; common stock continues on Nasdaq Capital Market under BCDA.
Company intends to submit a plan; risk of delisting if plan rejected or not accepted.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.